Laser Etching Effect on Application Mode of Universal Adhesive
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04814836 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 24, 2021
Last Update Posted : March 26, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Healthy Participant | Procedure: Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group) Procedure: Selective-etch mode with 35% phosphoric acid (K-ETCHANT) (SE-A group) Procedure: Total-etch mode with Er, Cr: YSGG laser (Waterlase MD) (TE-L group) Procedure: Selective-etch mode with Er, Cr: YSGG laser (Waterlase MD) (SE-L group). Procedure: Self-etch mode Clearfil Universal Bond Quick (Kuraray, Japan) (SE group) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 41 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | This study was carried out to investigate different etching methods used for application modes of universal adhesive on clinical performance of non-carious cervical lesions. The 35% phosphoric acid (K-ETCHANT) or Er,Cr:YSGG laser (2780 nm, Waterlase MD, BioLase Technology, Inc.) etching was applied to the tooth before these application modes in order to bond the universal adhesive, Clearfil Universal Bond Quick. Accordingly, the restorations were completed with 5 different application methods to five different teeth. The allocation of etching method and application mode on each tooth was determined in an order that was assigned by Biostatistics Department. This randomization was blinded to participants and evaluators. It was not known which etching method and application mode was applied to which teeth of the participants. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Clinical Evaluation of Cervical Composite Restorations Placed Using Universal Adhesive in Different Modes and Different Etching Methods |
| Actual Study Start Date : | July 10, 2019 |
| Actual Primary Completion Date : | January 10, 2021 |
| Estimated Study Completion Date : | March 25, 2025 |
| Arm | Intervention/treatment |
|---|---|
|
Group I
Total-etch mode with 35% phosphoric acid
|
Procedure: Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group)
35% phosphoric acid was applied to enamel and dentin for 10 s, washed and dried for 5 s. The universal adhesive, Clearfil Universal Bond Quick (CBQ) was applied to enamel and dentin surfaces with a single-use applicator, then gently air-dried for 5 s without waiting, and light-cured for 10 s. |
|
Group II
Selective-etch mode with 35% phosphoric acid
|
Procedure: Selective-etch mode with 35% phosphoric acid (K-ETCHANT) (SE-A group)
35% phosphoric acid was used only on enamel for 10 s, then washed and dried for 5 seconds. Subsequently, the adhesive was applied in a similar manner to the TE-A group. |
|
Group III
Total-etch mode with laser (Er,Cr:YSGG)
|
Procedure: Total-etch mode with Er, Cr: YSGG laser (Waterlase MD) (TE-L group)
the enamel margin and dentin surfaces of lesions were irradiated with an Er,Cr:YSGG laser (2780 nm, Waterlase MD, BioLase Technology, Inc., San Clemente, CA). Then the adhesive was applied in a similar manner to the TE-A group. |
|
Group IV
Selective-etch mode with laser (Er,Cr:YSGG)
|
Procedure: Selective-etch mode with Er, Cr: YSGG laser (Waterlase MD) (SE-L group).
The laser system was applied in the same way as described in the TE-L group only on enamel surface. Subsequently, the adhesive was applied in the same way as described in the TE-A group. |
|
Group V
Self-etch mode
|
Procedure: Self-etch mode Clearfil Universal Bond Quick (Kuraray, Japan) (SE group)
Universal adhesive system (CBQ) was applied to enamel and dentin surfaces without any previous etching. Then gently air-dried for 5 s without waiting, and light-cured for 10 s. |
- Retention, [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]
The retention criterion determines how long a restorative material functions in the oral environment, it is the most important criterion that shows the success of the material.
Alpha: The restoration is present. Charlie: The restoration is absent.
- Marginal Discoloration [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]
The marginal discoloration that occur at the edge staining restoration boundaries are generally thought to be due to microleakage.
Alpha: No discoloration at margins. Bravo: Shallow discoloration, clinically acceptable. Charlie: Deep discoloration clinically unacceptable.
- Marginal Adaptation [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]
Marginal adaptation is achieved by fully ensuring the integrity of the tooth-restoration joint border.
Alpha: Restoration is closely adapted to the tooth. Bravo: Visible evidence of a crevice along the margin, dentin not exposed, clinically acceptable.
Charlie: Explorer penetrates into crevice, dentin is exposed; clinically unacceptable.
- Color match [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]
Color match is the evaluation of the restoration according to the darkening or lightening of the color, taking into account the tooth tissue surrounding restoration.
Alpha:Matches tooth. Bravo: Acceptable mismatch. Charlie:Unacceptable mismatch.
- Post-op Hypersensitivity [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]Determination of sensitivity after restorations are placed. Alpha: Absent. Charlie: Present; clinically unacceptable.
- Secondary Caries [ Time Frame: From baseline to 2 year the change of restorations was evaluated ]
Secondary caries is the progression of caries in the tooth tissue adjacent to the restorations. Caries formation means restoration failure.
Alpha: Absent. Charlie: Present; clinically unacceptable.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Participants were 18 years of age or older,
- no possible health problems (such as allergies) related to resin-based restorations,
- good general health,
- having at least five non-carious cervical lesions.
- The depth of the lesions were at least 1 mm, without carious, not previously restored, having teeth with vital, enamel and dentin tissue.
Exclusion Criteria
- Participant had fewer than 20 teeth,
- having poor oral hygiene,
- uncontrolled periodontal disease,
- xerostomia,
- pregnancy or breastfeeding possible health problems (such as allergy) related to resin-based restorations,
- having bleaching treatment or orthodontic treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04814836
| Turkey | |
| Hacettepe University Faculty of Dentistry | |
| Ankara, Turkey, 06100 | |
| Principal Investigator: | A. Ruya Yazici | Hacettepe University Faculty of Dentistry |
Publications:
| Responsible Party: | A Ruya Yazici, Professor, Hacettepe University |
| ClinicalTrials.gov Identifier: | NCT04814836 |
| Other Study ID Numbers: |
KA180076 |
| First Posted: | March 24, 2021 Key Record Dates |
| Last Update Posted: | March 26, 2021 |
| Last Verified: | March 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
non-carious cervical lesions universal adhesives laser etching |

